212 related articles for article (PubMed ID: 36029101)
21. Mutation analysis of 419 family and prenatal diagnosis of 339 cases of spinal muscular atrophy in China.
Sun Y; Kong X; Zhao Z; Zhao X
BMC Med Genet; 2020 Jun; 21(1):133. PubMed ID: 32552676
[TBL] [Abstract][Full Text] [Related]
22. Impact of fetal or child loss on parents' perceptions of non-invasive prenatal diagnosis for autosomal recessive conditions.
Pisnoli L; O'Connor A; Goldsmith L; Jackson L; Skirton H
Midwifery; 2016 Mar; 34():105-110. PubMed ID: 26821974
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic strategies for spinal muscular atrophy: SMN and beyond.
Bowerman M; Becker CG; Yáñez-Muñoz RJ; Ning K; Wood MJA; Gillingwater TH; Talbot K;
Dis Model Mech; 2017 Aug; 10(8):943-954. PubMed ID: 28768735
[TBL] [Abstract][Full Text] [Related]
24. Drugs, genes and screens: The ethics of preventing and treating spinal muscular atrophy.
Gyngell C; Stark Z; Savulescu J
Bioethics; 2020 Jun; 34(5):493-501. PubMed ID: 31770817
[TBL] [Abstract][Full Text] [Related]
25. Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy.
Passini MA; Bu J; Richards AM; Kinnecom C; Sardi SP; Stanek LM; Hua Y; Rigo F; Matson J; Hung G; Kaye EM; Shihabuddin LS; Krainer AR; Bennett CF; Cheng SH
Sci Transl Med; 2011 Mar; 3(72):72ra18. PubMed ID: 21368223
[TBL] [Abstract][Full Text] [Related]
26. Mechanistic principles of antisense targets for the treatment of spinal muscular atrophy.
Singh NN; Lee BM; DiDonato CJ; Singh RN
Future Med Chem; 2015; 7(13):1793-808. PubMed ID: 26381381
[TBL] [Abstract][Full Text] [Related]
27. Prenatal transplantation of human amniotic fluid stem cells for spinal muscular atrophy.
Peng SY; Shaw SW
Curr Opin Obstet Gynecol; 2018 Apr; 30(2):111-115. PubMed ID: 29489501
[TBL] [Abstract][Full Text] [Related]
28. Advances in Treatment of Spinal Muscular Atrophy - New Phenotypes, New Challenges, New Implications for Care.
Schorling DC; Pechmann A; Kirschner J
J Neuromuscul Dis; 2020; 7(1):1-13. PubMed ID: 31707373
[TBL] [Abstract][Full Text] [Related]
29. Molecular analysis and prenatal prediction of spinal muscular atrophy in Chinese patients by the combination of restriction fragment length polymorphism analysis, denaturing high-performance liquid chromatography, and linkage analysis.
Chen WJ; Wu ZY; Lin MT; Su JF; Lin Y; Murong SX; Wang N
Arch Neurol; 2007 Feb; 64(2):225-31. PubMed ID: 17296838
[TBL] [Abstract][Full Text] [Related]
30. Current treatments of spinal muscular atrophy in adults.
Cintas P
Rev Neurol (Paris); 2023; 179(1-2):106-113. PubMed ID: 36550013
[TBL] [Abstract][Full Text] [Related]
31. Spinal muscular atrophy: diagnosis and management in a new therapeutic era.
Arnold WD; Kassar D; Kissel JT
Muscle Nerve; 2015 Feb; 51(2):157-67. PubMed ID: 25346245
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of Cell-Penetrating Peptide Delivery of Antisense Oligonucleotides for Therapeutic Efficacy in Spinal Muscular Atrophy.
Hammond SM; Abendroth F; Gait MJ; Wood MJA
Methods Mol Biol; 2019; 2036():221-236. PubMed ID: 31410800
[TBL] [Abstract][Full Text] [Related]
33. Spinal muscular atrophy--recent therapeutic advances for an old challenge.
Faravelli I; Nizzardo M; Comi GP; Corti S
Nat Rev Neurol; 2015 Jun; 11(6):351-9. PubMed ID: 25986506
[TBL] [Abstract][Full Text] [Related]
34. Prenatal diagnosis of spinal muscular atrophy in Turkish families.
Erdem H; Dayangaç D; Pehlivan S; Topaloglu H
Cent Eur J Public Health; 2001 Feb; 9(1):35-7. PubMed ID: 11243588
[TBL] [Abstract][Full Text] [Related]
35. Perspectives on Spinraza (Nusinersen) Treatment Study: Views of Individuals and Parents of Children Diagnosed with Spinal Muscular Atrophy.
Pacione M; Siskind CE; Day JW; Tabor HK
J Neuromuscul Dis; 2019; 6(1):119-131. PubMed ID: 30594933
[TBL] [Abstract][Full Text] [Related]
36. Population screening for spinal muscular atrophy: A mixed methods study of the views of affected families.
Boardman FK; Young PJ; Griffiths FE
Am J Med Genet A; 2017 Feb; 173(2):421-434. PubMed ID: 27792846
[TBL] [Abstract][Full Text] [Related]
37. [Detection of SMN gene deletions in spinal muscular atrophy].
Yang T; Yuan L; Liu T; Zhou W; Wu H; Zhao S; Shun L; Huo L; Ma S; Lin Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Apr; 15(2):95-7. PubMed ID: 9531649
[TBL] [Abstract][Full Text] [Related]
38. Antisense oligonucleotides for the treatment of spinal muscular atrophy.
Porensky PN; Burghes AH
Hum Gene Ther; 2013 May; 24(5):489-98. PubMed ID: 23544870
[TBL] [Abstract][Full Text] [Related]
39. [Studies on the molecular diagnosis and prenatal diagnosis of the spinal muscular atrophy carriers by multiplex ligation-dependent probe].
Zhu H; Hu Y; Li J; Yang Y; Wu X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):38-41. PubMed ID: 20140865
[TBL] [Abstract][Full Text] [Related]
40. Room to improve: The diagnostic journey of Spinal Muscular Atrophy.
Carter M; Tobin A; Coy L; McDonald D; Hennessy M; O'Rourke D
Eur J Paediatr Neurol; 2023 Jan; 42():42-46. PubMed ID: 36525883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
